研究者
J-GLOBAL ID：200901045349107440
更新日: 2023年06月15日
恵美 学
エミ マナブ | EMI MANABU
所属機関・部署：
競争的資金等の研究課題 (1件)：
- 2021 - 2023 食道癌において口腔内および食道内細菌叢がどのように影響するか?
論文 (13件)：
-
Ohsawa, Manato, Hamai, Yoichi, Emi, Manabu, Ibuki, Yuta, Kurokawa, Tomoaki, Yoshikawa, Toru, Hirohata, Ryosuke, Kitasaki, Nao, Okada, Morihito. Real-world clinical outcomes of nivolumab and taxane as a second- or later-line therapy for recurrent or unresectable advanced esophageal squamous cell carcinoma. FRONTIERS IN ONCOLOGY. 2023. 13
-
Miyoshi, Shota, Nishibuchi, Ikuno, Murakami, Yuji, Katsuta, Tsuyoshi, Imano, Nobuki, Hirokawa, Junichi, Hamai, Yoichi, Emi, Manabu, Okada, Morihito, Nagata, Yasushi. Long-term results of chemoradiotherapy with elective nodal irradiation for resectable locally advanced esophageal cancer in three-dimensional planning system. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY. 2023. 28. 3. 382-391
-
Hamai, Yoichi, Emi, Manabu, Ibuki, Yuta, Kurokawa, Tomoaki, Yoshikawa, Toru, Ohsawa, Manato, Hirohata, Ryosuke, Kitasaki, Nao, Okada, Morihito. Ability of Blood Cell Parameters to Predict Clinical Outcomes of Nivolumab Monotherapy in Advanced Esophageal Squamous Cell Carcinoma. ONCOTARGETS AND THERAPY. 2023. 16. 263-273
-
Ohsawa, Manato, Hamai, Yoichi, Emi, Manabu, Ibuki, Yuta, Kurokawa, Tomoaki, Yoshikawa, Toru, Hirohata, Ryosuke, Kitasaki, Nao, Okada, Morihito. Blood biomarkers as predictors of pathological lymph node metastasis in clinical stage T1N0 esophageal squamous cell carcinoma. DISEASES OF THE ESOPHAGUS. 2022. 36. 1
-
Hamai, Yoichi, Emi, Manabu, Ibuki, Yuta, Kurokawa, Tomoaki, Yoshikawa, Toru, Ohsawa, Manato, Hirohata, Ryosuke, Kitasaki, Nao, Okada, Morito. Correlation Between Tumor Uptake on FDG-PET and Malignant Features in Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemotherapy Followed by Surgery. ANTICANCER RESEARCH. 2022. 42. 12. 6037-6045
もっと見る
受賞 (1件)：
- 2012/10/16 - 国際食道学会 最優秀演題賞
前のページに戻る
